0
Medical News & Perspectives |

A "Safer" Cigarette? Prove It, Say Critics

Joan Stephenson, PhD
JAMA. 2000;283(19):2507-2508. doi:10.1001/jama.283.19.2507.
Text Size: A A A
Published online

Extract

A controversial marketing campaign touting a cigarette-like product as less likely than conventional cigarettes to cause cancer and other smoking-related illnesses is drawing fire from public health officials, scientists, and antismoking advocates. The new marketing effort comes only 4 weeks after the US Supreme Court ruled that the Food and Drug Administration (FDA) lacks the authority to regulate tobacco products.

At R. J. Reynolds Tobacco Holdings (RJR) Inc's annual shareholders meeting, CEO Andrew J. Schindler announced that RJR was marketing a cigarette called Eclipse with the claim that the product may present smokers with "less risk of cancer and certain other diseases, such as chronic bronchitis and possibly emphysema."As part of the new marketing campaign, RJR is using newspaper and magazine advertising along with direct marketing, aimed primarily at consumers in the Dallas–Fort Worth area. Until now, the product has been available only in test markets in Chattanooga, Tenn; Lincoln, Neb; and parts of Atlanta.

Figures in this Article

Topics

cigarettes

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Place holder to copy figure label and caption

Magazines, primarily in the Dallas–Fort Worth area, will feature this advertisement for Eclipse, which claims the reduced-smoke product may present less risk of cancer and other smoking-related illnesses than conventional cigarettes. Critics charge that no independent studies exist to support such claims. (Credit: PRN)

Graphic Jump Location

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();